scispace - formally typeset
K

Karin M. Hjelle

Researcher at Haukeland University Hospital

Publications -  24
Citations -  1271

Karin M. Hjelle is an academic researcher from Haukeland University Hospital. The author has contributed to research in topics: Renal cell carcinoma & Clear cell renal cell carcinoma. The author has an hindex of 12, co-authored 23 publications receiving 1106 citations. Previous affiliations of Karin M. Hjelle include University of Bergen.

Papers
More filters
Journal ArticleDOI

Articular cartilage defects in 1,000 knee arthroscopies

TL;DR: The contention that articular cartilage defects are common in patients with symptomatic knees requiring arthroscopy is supported, and the prevalence of patients who might benefit from cartilage repair surgery is calculated.
Journal ArticleDOI

Observation should be considered as an alternative in management of renal masses in older and comorbid patients.

TL;DR: Management of renal masses by observation among older and comorbid patients seems to give acceptable results with regard to OS and CSS rates after 5 yr, but the risk of disease progression is significantly higher in patients with larger sized renal masses (>4 cm).
Journal ArticleDOI

Transcriptome Sequencing (RNAseq) Enables Utilization of Formalin-Fixed, Paraffin-Embedded Biopsies with Clear Cell Renal Cell Carcinoma for Exploration of Disease Biology and Biomarker Development.

TL;DR: Analysis of RNAseq results from FFPE biopsies with corresponding RNAlater stored samples from clear cell renal cell carcinoma patients revealed the presence of gene signatures of cancer and nephrotoxicity, renal damage and immune response, thereby expanding the utility of archival tissue specimens.
Journal ArticleDOI

A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use.

TL;DR: After 8 years of clinical use, the outcome measures of the new risk-stratified follow-up programme for surgically treated localized renal cell carcinoma seem to be within acceptable ranges.